Bionano Genomics, Inc.
Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
Funding history
About Bionano Genomics, Inc.
How much funding has Bionano Genomics, Inc. raised?
Bionano Genomics, Inc. has raised $75.0M in total funding. The most recent round was Series D.
Where is Bionano Genomics, Inc. headquartered?
Bionano Genomics, Inc. is headquartered in San Diego, CA.
What does Bionano Genomics, Inc. do?
Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
What problem does Bionano Genomics, Inc. solve?
Existing tools (karyotyping, FISH, chromosomal microarray, and next-generation sequencing) lack the resolution and efficiency to detect the full range of genomic structural variation, limiting disease identification and treatment.
What's Bionano Genomics, Inc.'s solution?
Bionano's optical genome mapping (OGM) systems (Stratys, Saphyr) and analysis software reveal all classes of structural variants and combine that data with NGS/CMA data for comprehensive variant interpretation.
What makes Bionano Genomics, Inc. different?
OGM offers digital precision in a rapid, highly automated workflow, and the page notes over 500 publications now cite OGM solutions.
What makes Bionano Genomics, Inc. notable?
This publicly traded (NASDAQ: BNGO) San Diego genome-mapping company was founded in 2003 by Han Cao, spun out of DARPA-funded nanotechnology research he led at Princeton.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.